Self-Assessed Severity as a Determinant of Coronavirus Disease 2019 Symptom Specificity: A Longitudinal Cohort Study
- PMID: 35152299
- PMCID: PMC8903379
- DOI: 10.1093/cid/ciac129
Self-Assessed Severity as a Determinant of Coronavirus Disease 2019 Symptom Specificity: A Longitudinal Cohort Study
Abstract
Coronavirus disease 2019 symptom definitions rarely include symptom severity. We collected daily nasal swab samples and symptom diaries from contacts of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) case patients. Requiring ≥1 moderate or severe symptom reduced sensitivity to predict SARS-CoV-2 shedding from 60.0% (95% confidence interval [CI], 52.9%-66.7%) to 31.5% (95% CI, 25.7%- 38.0%) but increased specificity from 77.5% (95% CI, 75.3%-79.5%) to 93.8% (95% CI, 92.7%-94.8%).
Keywords: COVID-19; SARS-CoV-2; screening; severity; symptoms.
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures

References
-
- Gidengil CA, Fischer SH, Broten N.. A framework for evaluating approaches to symptom screening in the workplace during the COVID-19 pandemic. 2020. Available at: https://www.rand.org/pubs/perspectives/PEA653-1.html. Accessed 6 August 2021.
-
- Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): 2020 interim case definition, approved august 5, 2020. Available at: https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-2.... Accessed 3 August 2021.